The efficacy of Iguratimod, and adding Adalimumab in patients with active rheumatoid arthritis: an open label multicenter randomized parallel study. The efficacy of Iguratimod, and adding Adalimumab in patients with active rheumatoid arthritis: an o ...
The efficacy of Iguratimod, and adding Adalimumab in patients with active rheumatoid arthritis: an open label multicenter randomized parallel study. - The efficacy of Iguratimod, and adding Adalimumab in patients with active rheumatoid arthritis. The efficacy of Iguratimod, and adding Adalimumab in patients with active rheumatoid arthritis: an o ...
Rheumatoid arthritis
Administer MTX 6-16mg/week for 12 weeks to patients with MDA-RA. If patients can't take MTX, administer IGU 25-50mg/day or Tac 1.5-3.0mg/day for 12 weeks.
Administer ADA 40mg/2weeks for 24weeks additionally, in case of MDA taking MTX or IGU, Tac for 12 weeks. If patients maintain remission for 24weeks, discontinue ADA by their own will, after 48 weeks administering ADA. Administer MTX 6-16mg/week for 12 weeks to patients with MDA-RA. If patients can't take MTX, administ ...